Skip to main content
. Author manuscript; available in PMC: 2023 Jul 6.
Published in final edited form as: ACS Chem Neurosci. 2020 Jan 8;11(3):258–267. doi: 10.1021/acschemneuro.9b00338

Table 1. HDAC panel assay.

The selectivity of T-3796106 and T-3793168 was analyzed based on HDAC enzyme inhibition. [a] The compound activity against 11 HDACs represented with the IC50 value. The IC50 values shown are the mean values of duplicate measurements; the numbers in parentheses represent each data. [b] No inhibition or compound activity that could not be fit to an IC50 curve.

Target Compounds IC50 (nM)a
T-3796106 T-3793168 Tubastatin A
HDAC1 6200 (5820-6660) b >10000
HDAC2 >10000 b >10000
HDAC3 4000 (3480-4470) b >10000
HDAC8 >1000 5600 (4170-7080) >1000
HDAC4 6200 (5970-6380) >10000 6200 (6030-6330)
HDAC5 1700 (1610-1800) 2300 (1550-3060) 1900 (1580-2310)
HDAC7 1100 (1050-1130) 5800 (4000-7660) 590 (530-641)
HDAC9 2700 (2540-2840) 5000 (4950-4960) 1100 (913-1380)
HDAC6 12 (12.3-12.4) 86 (67.4-104) 15 (14.3-15.2)
HDAC10 >10000 b >10000
HDAC11 >10000 b >10000